Treatments from Toxins: The Therapeutic Potential of Clostridial Neurotoxins

Author:   Keith Alan Foster (Syntaxin Ltd., Health Protection Agency, Wiltshire, UK) ,  Peter Hambleton (Syntaxin Ltd., Health Protection Agency, Wiltshire, UK) ,  Clifford C. Shone (Syntaxin Ltd., Health Protection Agency, Wiltshire, UK) ,  Peter Hambleton (Syntaxin Ltd., Health Protection Agency, Wiltshire, UK Syntaxin Ltd., Health Protection Agency, Wiltshire, UK)
Publisher:   Taylor & Francis Inc
ISBN:  

9780849327094


Pages:   312
Publication Date:   02 November 2006
Format:   Hardback
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Our Price $546.00 Quantity:  
Add to Cart

Share |

Treatments from Toxins: The Therapeutic Potential of Clostridial Neurotoxins


Overview

As little as two decades ago, deliberately injecting botulinum toxin into patients would have seemed foolhardy at best and criminal at worst. The increased clinical use of botulinum toxins has expanded the body of knowledge available on the structure and function of these proteins. This knowledge can be applied to topics as varied as therapies based on the endopeptidase activity of the toxins, vaccine development, protection against botulism, and vectors for neuronal drug delivery. Based on recent scientific and clinical information from top international authorities, Treatments from Toxins: The Therapeutic Potential of Clostridial Neurotoxins reviews the status of current research and development and identifies significant developments. Drawing on their vast experience in this field, the editors present the basic background of the bacteriology and genetics of the neurotoxigenic clostridia, a history of the discovery of the neurotoxins, and an overview of the tetanus and botulism diseases. The chapters detailing common medical applications of the toxins cover side effects and novel uses, including neuronal drug delivery strategies, and provide a fresh look at what can still be achieved. They also explore the toxins as potential threat agents and the advent of the therapeutic use of botulinum toxins. Highlighting the pitfalls, successes, and challenges that exist when engineering complex proteins, the book brings together the clinical and theoretical worlds. It presents a broad overview of the current status of botulinum research and its clinical applications.

Full Product Details

Author:   Keith Alan Foster (Syntaxin Ltd., Health Protection Agency, Wiltshire, UK) ,  Peter Hambleton (Syntaxin Ltd., Health Protection Agency, Wiltshire, UK) ,  Clifford C. Shone (Syntaxin Ltd., Health Protection Agency, Wiltshire, UK) ,  Peter Hambleton (Syntaxin Ltd., Health Protection Agency, Wiltshire, UK Syntaxin Ltd., Health Protection Agency, Wiltshire, UK)
Publisher:   Taylor & Francis Inc
Imprint:   CRC Press Inc
Dimensions:   Width: 15.60cm , Height: 2.20cm , Length: 23.40cm
Weight:   0.572kg
ISBN:  

9780849327094


ISBN 10:   0849327091
Pages:   312
Publication Date:   02 November 2006
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Reviews

Author Information

Keith Alan Foster, Peter Hambleton, Clifford C. Shone

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

NOV RG 20252

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List